Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation-Reference-Cited by-同舟云学术

Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation

Published:2019-07-02 Issue:7 Volume:14 Page:e0219204
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gilson Pauline,Franczak Claire,Dubouis Ludovic,Husson Marie,Rouyer Marie,Demange Jessica,Perceau Marie,Leroux Agnès,Merlin Jean-Louis,Harlé Alexandre^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;F Bray;CA Cancer J Clin,2018

2. Colorectal cancer;H Brenner;Lancet,2014

3. Diagnostic accuracy of computed tomography for colon cancer staging: a systematic review;AM Leufkens;Scand J Gastroenterol,2011

4. SEER Cancer Statistics Review, 1975–2014, National Cancer Institute, Bethesda, MD, https://seer.cancer.gov/csr/1975_2014/sections.html. Accessed on 2018 april 9.

5. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;RG Amado;J Clin Oncol,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of the Idylla microsatellite instability test in endometrial cancer;Molecular and Cellular Probes;2024-10

2. Exploring the Influence of c-Jun N terminal Kinase Scaffold Proteins on the Spatiotemporal Regulation of JNK Activation in Pancreatic Ductal Adenocarcinoma;2024-07-25

3. Colorectal cancer: Genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials;Gene;2024-01

4. Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers;Scientific Reports;2023-08-09

5. Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator;The Oncologist;2023-03-24